Cargando…
Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection–Related Hepatocellular Carcinoma
BACKGROUND: Patients with hepatitis B virus (HBV) infection are at high risk of hepatocellular carcinoma (HCC). This study aimed to evaluate the expression of microRNA-324-3p (miR-324-3p) in HBV-related HCC and explore the clinical significance of serum miR-324-3p and other available biomarkers in t...
Autores principales: | Zhao, Li, Yang, Qian, Liu, Jianbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232384/ https://www.ncbi.nlm.nih.gov/pubmed/34189151 http://dx.doi.org/10.1093/ofid/ofab108 |
Ejemplares similares
-
Serum/Plasma MicroRNAs as Biomarkers for HBV-Related Hepatocellular Carcinoma in China
por: Yin, Wen, et al.
Publicado: (2015) -
Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma
por: Zhu, Hao-Tu, et al.
Publicado: (2016) -
Increased Expression of miR-487b Is Associated With Poor Prognosis and Tumor Progression of HBV-Related Hepatocellular Carcinoma
por: Cao, Xiangang, et al.
Publicado: (2020) -
MicroRNA profile in HBV-induced infection and hepatocellular carcinoma
por: Wang, Guanyu, et al.
Publicado: (2017) -
The expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance
por: Zhang, Han-qun, et al.
Publicado: (2017)